Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis: A Multi-center, Randomized, Double Blind, Placebo-controlled Trial. The STATLiver Trial

NCT04072601 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Hvidovre as lead sponsor.

NCT NCT04072601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04072601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis: A Multi-center, Randomized, Double Blind, Placebo-controlled Trial. The STATLiver Trial
Lead sponsor
Copenhagen University Hospital, Hvidovre
Phase
Phase 4
Overall status
Terminated
Start date
November 8, 2019
Completion date
January 10, 2023
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhoses